A brief history of and future prospects for pneumococcal vaccination in Malaysia

Alex J. J. Lister; Evelin Dombay; David W. Cleary; Lokman H. Sulaiman; Stuart C. Clarke

doi:10.1186/s41479-023-00114-8

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman, Stuart C. Clarke^*

^*Corresponding author for this work

Microbiology and Infection

Research output: Contribution to journal › Review article › peer-review

34 Downloads (Pure)

Abstract

Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.

Original language	English
Article number	12
Number of pages	8
Journal	Pneumonia
Volume	15
Issue number	1
Early online date	25 Aug 2023
DOIs	https://doi.org/10.1186/s41479-023-00114-8
Publication status	E-pub ahead of print - 25 Aug 2023

Keywords

Malaysia
Pneumonia
Pneumococcal vaccination
Pneumococcal disease
Vaccination policy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s41479-023-00114-8Licence: Creative Commons: Attribution (CC BY)

ListerA2023BriefFinal published version, 1 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{788c590427c1426783fe7d4b97fad528,

title = "A brief history of and future prospects for pneumococcal vaccination in Malaysia",

abstract = "Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.",

keywords = "Malaysia, Pneumonia, Pneumococcal vaccination, Pneumococcal disease, Vaccination policy",

author = "Lister, {Alex J. J.} and Evelin Dombay and Cleary, {David W.} and Sulaiman, {Lokman H.} and Clarke, {Stuart C.}",

year = "2023",

month = aug,

day = "25",

doi = "10.1186/s41479-023-00114-8",

language = "English",

volume = "15",

journal = "Pneumonia",

issn = "2200-6133",

publisher = "BioMed Central Ltd",

number = "1",

}

TY - JOUR

T1 - A brief history of and future prospects for pneumococcal vaccination in Malaysia

AU - Lister, Alex J. J.

AU - Dombay, Evelin

AU - Cleary, David W.

AU - Sulaiman, Lokman H.

AU - Clarke, Stuart C.

PY - 2023/8/25

Y1 - 2023/8/25

N2 - Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.

AB - Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme. Data on pneumococcal serotype epidemiology is vital for informing national vaccination policy. However, there remains a lack of representative population-based pneumococcal surveillance in Malaysia to help both the assessment of vaccine effectiveness in the country and to shape future vaccine policy. This review explores the history of pneumococcal vaccination, the burden of pneumococcal disease in Malaysia, and offers an insight into the prospects for reducing pneumococcal disease in Malaysia.

KW - Malaysia

KW - Pneumonia

KW - Pneumococcal vaccination

KW - Pneumococcal disease

KW - Vaccination policy

U2 - 10.1186/s41479-023-00114-8

DO - 10.1186/s41479-023-00114-8

M3 - Review article

SN - 2200-6133

VL - 15

JO - Pneumonia

JF - Pneumonia

IS - 1

M1 - 12

ER -

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this